Tech Company Financing Transactions
Progyny Funding Round
Progyny, operating out of New York, secured investment capital from Kleiner Perkins Caufield & Byers, Merck Serono Ventures and SR One Capital Management.
Transaction Overview
Company Name
Announced On
4/22/2015
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The funding will enable the company to expand operations.
Company Information
Company Status
Publicly-held
Industry
Healthcare Services
Mailing Address
99 Hudson St. 7th Floor
New York, NY 10013
USA
New York, NY 10013
USA
Phone
Website
Email Address
Overview
Progyny (Nasdaq: PGNY) is the first company to provide fertility patients with easy accessibility to high quality doctors, price transparency, and financing, coupled with extraordinary clinical expertise and proprietary clinical solutions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Schlanger
Chief Financial Officer
Mark Livingston
Chief Medical Officer
Alan Copperman
Chief Operating Officer
Peter Anevski
VP - Client Services
Lisa Greenbaum
VP - Marketing
Risa Fisher
Browse more venture capital transactions:
Prev: 4/22/2015: Stratim venture capital transaction
Next: 4/22/2015: Deep Information Sciences venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs